By using a tissue microarray (TMA) and staining for PPARγ immunohistochemically, Rogenhofer et al. found that protein levels of PPARγ were increased in advanced PC compared to both low-risk PC and benign prostate hyperplasia (BPH) [49]. This evidence concerns the gene PPARG and pachyonychia congenita.